Results 311 to 320 of about 1,439,975 (404)
Clinical significance of small dense low-density lipoprotein cholesterol measurement in type 2 diabetes. [PDF]
Hirano T.
europepmc +1 more source
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló+5 more
wiley +1 more source
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial. [PDF]
Aggarwal R+12 more
europepmc +1 more source
Use of LC‐MS to characterize host cell protein removal during depth filtration
Abstract The removal of host cell proteins (HCPs) is crucial in biopharmaceutical production, as residual impurities can impact product safety and efficacy. While a number of studies have demonstrated that depth filtration can provide significant HCP removal, there is little information on its effectiveness in removing specific HCPs.
Liang‐Kai Chu+3 more
wiley +1 more source
Effects of Cumulative Low-Density Lipoprotein Cholesterol Exposure on Endothelial Function in Subjects Receiving Lipid-Lowering Drugs. [PDF]
Yamaji T+9 more
europepmc +1 more source
Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor
Abstract Neutrophils are important components of the immune system and play a key role in defending against pathogenic infections and responding to inflammatory cues, including cancer. Their dysregulation indicates potential disease risk factors. However, their functional importance in disease progression has often been underestimated due to their ...
Wenpeng Cai+6 more
wiley +1 more source
Impact of Elevated Low-Density Lipoprotein and the Risk of Acute Coronary Syndrome in Rheumatoid Arthritis: A Retrospective Study. [PDF]
Sherwani Y, Al-Ezzi S, Thambidorai S.
europepmc +1 more source